TY  - JOUR 
AU  - Delgado Ureña, Mayte
AU  - Ortega, Francisco G.
AU  - Miguel-Pérez, Diego de
AU  - Rodríguez Martínez, Alba
AU  - García Puche, José Luis
AU  - Ilyine, Hugh
AU  - Lorente Acosta, José Antonio
AU  - Expósito Hernández, José
AU  - Garrido Navas, María del Carmen
AU  - Delgado Ramírez, Miguel
AU  - Serrano, M. Jose
PY  - 2018
UR  - http://hdl.handle.net/10481/57895
AB  - The use of circulating tumor cells (CTCs) as indicators of treatment response in metastatic colorectal
cancer (mCRC) needs to be clarified. The objective of this study is to compare the Response Evaluation Criteria in Solid
Tumors (RECIST) with the...
LA  - eng
PB  - Springer Nature
KW  - Metastatic colorectal cancer
KW  - Bevacizumab
KW  - Circulating tumor cells
KW  - RECIST
KW  - CyCAR
KW  - Prognosis
TI  - Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients
DO  - 10.1186/s12967-018-1624-2
ER  -